Related Articles
Clinical use of trastuzumab combined with different chemotherapy regimens in multi‑line treatment of advanced human epidermal growth factor receptor 2‑positive gastric cancer: A case report
Individualized drug screening based on next generation sequencing and patient derived xenograft model for pancreatic cancer with bone metastasis
Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins
A potential novel therapy for FGFR1‑amplified pancreatic cancer with bone metastasis, screened by next‑generation sequencing and a patient‑derived xenograft model
Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers